Live News Categoriesmarket

SGMT.O (SGMT.O) News

Track canonical SquawkNews coverage tagged to SGMT.O, SGMT.O. This hub brings together deduplicated headlines about market instrument, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 1 indexed stories across 1 publication days and is ordered by the same first-publication timeline used by LiveCast.

Symbol SGMT.O Asset market Sector Markets 90 days 1 Updated Sep 30, 2026, 10:03 AM UTC Open live news feed

M Sagimet reports 52-week Phase 3 extension data showing 56.7% IGA success for denifanstat Sagimet Biosciences said 52-week results from Ascletis’ Phase 3 open-label extension of denifanstat in moderate to severe acne showed 56.7% IGA success, with sustained improvements and no adverse event-related permanent EARNINGS | Sep 30, 2026, 10:03 AM UTC